New Haven biotech Rib-X going public
(11/28/2011) Hartford Business Journal - New Haven antibiotics developer Rib-X Pharmaceuticals Inc., in which Connecticut taxpayers hold a stake, is going public.
The biopharmaceutical company announced Monday that it has filed paperwork with the U.S. Securities and Exchange Commission for a proposed initial public offering of common stock.
Rib-X did not disclose the number of shares or the price of the offering, but the Dow Jones Newswire reports that the company is looking to raise $80 million.
Follow this link for more information.